contact us to

get started

Contact Sales
On-Demand Webinar

2021 State of Revenue for Life Sciences

Learn what pharma and medtech executives think about revenue management in 2021.

Revenue management is business critical, yet the majority of executives at pharmaceutical and medtech companies believe their industry could better optimize revenue activities to maximize growth.

Hear from our industry experts as they present reasons for this disconnect and other key insight from the 2021 State of Revenue Report – a compilation of findings from a recent survey of executives who are directly responsible for revenue growth at large life sciences companies. We’ll discuss how revenue management challenges are having an impact on business and how companies are responding. We’ll also uncover the areas that executives view as their biggest opportunities for success.

Topics covered include:

  • Preparing for regulatory change under the new administration
  • Addressing global pricing-related challenges
  • The impact of technology on revenue activities
  • Expected business results from better revenue management

You might also like

2021-state-of-revenue-report-resources-thumbnail
Whitepaper
Whitepaper
Whitepaper
2021 State of Revenue Report
Discover how executives are dealing with today’s challenges and where they think the biggest opportunities lie. VIEW Whitepaper
Video
Video
Video
Global Tender Management Overview
Improve you overall tender profitability and win rates and generate significant revenue for your company with Global Tender Management by Model N. VIEW Video
340b-cover
Whitepaper
Whitepaper
Whitepaper
Best practices for complying with 340B
Read this white paper to learn how you can improve the chargeback process, generate an audit trail, and ensure correct 340B pricing. VIEW Whitepaper

Start typing and press Enter to search